Briel M - Search Results

1

The prognostic and predictive value of sstr₂-immunohistochemistry and sstr₂-targeted imaging in neuroendocrine tumors.

Brunner P, Jörg AC, Glatz K, Bubendorf L, Radojewski P, Umlauft M, Marincek N, Spanjol PM, Krause T, Dumont RA, Maecke HR, Müller-Brand J, Briel M, Schmitt A, Perren A, Walter MA. Brunner P, et al. Among authors: briel m. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):468-475. doi: 10.1007/s00259-016-3486-2. Epub 2016 Aug 18. Eur J Nucl Med Mol Imaging. 2017. PMID: 27539020 Free article. Clinical Trial.

2

Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials.

Walter MA, Briel M, Christ-Crain M, Bonnema SJ, Connell J, Cooper DS, Bucher HC, Müller-Brand J, Müller B. Walter MA, et al. Among authors: briel m. BMJ. 2007 Mar 10;334(7592):514. doi: 10.1136/bmj.39114.670150.BE. Epub 2007 Feb 19. BMJ. 2007. PMID: 17309884 Free PMC article.

3

Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers.

Imhof A, Brunner P, Marincek N, Briel M, Schindler C, Rasch H, Mäcke HR, Rochlitz C, Müller-Brand J, Walter MA. Imhof A, et al. Among authors: briel m. J Clin Oncol. 2011 Jun 10;29(17):2416-23. doi: 10.1200/JCO.2010.33.7873. Epub 2011 May 9. J Clin Oncol. 2011. PMID: 21555692 Clinical Trial.

4

The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis.

Fuchs M, Briel M, Daikeler T, Walker UA, Rasch H, Berg S, Ng QK, Raatz H, Jayne D, Kötter I, Blockmans D, Cid MC, Prieto-González S, Lamprecht P, Salvarani C, Karageorgaki Z, Watts R, Luqmani R, Müller-Brand J, Tyndall A, Walter MA. Fuchs M, et al. Among authors: briel m. Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):344-53. doi: 10.1007/s00259-011-1967-x. Epub 2011 Nov 10. Eur J Nucl Med Mol Imaging. 2012. PMID: 22072285 Free article.

5

Cohort study of somatostatin-based radiopeptide therapy with [(90)Y-DOTA]-TOC versus [(90)Y-DOTA]-TOC plus [(177)Lu-DOTA]-TOC in neuroendocrine cancers.

Villard L, Romer A, Marincek N, Brunner P, Koller MT, Schindler C, Ng QK, Mäcke HR, Müller-Brand J, Rochlitz C, Briel M, Walter MA. Villard L, et al. Among authors: briel m. J Clin Oncol. 2012 Apr 1;30(10):1100-6. doi: 10.1200/JCO.2011.37.2151. Epub 2012 Mar 5. J Clin Oncol. 2012. PMID: 22393097

6

Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study.

Marincek N, Jörg AC, Brunner P, Schindler C, Koller MT, Rochlitz C, Müller-Brand J, Maecke HR, Briel M, Walter MA. Marincek N, et al. Among authors: briel m. J Transl Med. 2013 Jan 15;11:17. doi: 10.1186/1479-5876-11-17. J Transl Med. 2013. PMID: 23320604 Free PMC article. Clinical Trial.

7

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours.

Romer A, Seiler D, Marincek N, Brunner P, Koller MT, Ng QK, Maecke HR, Müller-Brand J, Rochlitz C, Briel M, Schindler C, Walter MA. Romer A, et al. Among authors: briel m. Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):214-22. doi: 10.1007/s00259-013-2559-8. Epub 2013 Oct 2. Eur J Nucl Med Mol Imaging. 2014. PMID: 24085501 Free article. Clinical Trial.

8

Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial.

Marincek N, Radojewski P, Dumont RA, Brunner P, Müller-Brand J, Maecke HR, Briel M, Walter MA. Marincek N, et al. Among authors: briel m. J Nucl Med. 2015 Feb;56(2):171-6. doi: 10.2967/jnumed.114.147256. Epub 2015 Jan 15. J Nucl Med. 2015. PMID: 25593116 Free article. Clinical Trial.

9

Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinoma.

Dumont RA, Seiler D, Marincek N, Brunner P, Radojewski P, Rochlitz C, Müller-Brand J, Maecke HR, Briel M, Walter MA. Dumont RA, et al. Among authors: briel m. Am J Nucl Med Mol Imaging. 2014 Dec 15;5(1):46-55. eCollection 2015. Am J Nucl Med Mol Imaging. 2014. PMID: 25625026 Free PMC article.

10

Towards tailored radiopeptide therapy.

Radojewski P, Dumont R, Marincek N, Brunner P, Mäcke HR, Müller-Brand J, Briel M, Walter MA. Radojewski P, et al. Among authors: briel m. Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1231-7. doi: 10.1007/s00259-015-3030-9. Epub 2015 Mar 20. Eur J Nucl Med Mol Imaging. 2015. PMID: 25792454 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters